Follicular Lymphoma
Showing NaN - NaN of 16
Untreated FolliculaR Lymphoma Treated With OBinituzumAb
Active, not recruiting
- Follicular Lymphoma
-
Pescara, Abruzzo, Italy
- +45 more
Nov 21, 2022
Follicular Lymphoma Trial in Worldwide (tisagenlecleucel)
Active, not recruiting
- Follicular Lymphoma
- tisagenlecleucel
-
Duarte, California
- +29 more
Nov 2, 2022
Non-Hodgkin Lymphoma, Follicular Lymphoma Trial in Worldwide (Betalutin)
Active, not recruiting
- Non-Hodgkin Lymphoma
- Follicular Lymphoma
-
Little Rock, Arkansas
- +95 more
Sep 9, 2022
Follicular Lymphoma, Marginal Zone Lymphoma Trial in Italy, Spain, United States (EO2463, lenalidomide, rituximab)
Recruiting
- Follicular Lymphoma
- Marginal Zone Lymphoma
- EO2463
- +2 more
-
Boston, Massachusetts
- +9 more
Jul 26, 2022
DLBCL, Follicular Lymphoma, Marginal Zone Lymphoma Trial in Worldwide (Ublituximab, Umbralisib, Bendamustine)
Terminated
- Diffuse Large B-Cell Lymphoma
- +4 more
- Ublituximab
- +2 more
-
Birmingham, Alabama
- +167 more
Jul 20, 2022
Follicular Lymphoma Trial in Worldwide (Rituximab, Lenalidomide, Rituximab - CHOP)
Active, not recruiting
- Follicular Lymphoma
- Rituximab
- +4 more
-
Concord, New South Wales, Australia
- +34 more
Jul 23, 2021
Follicular Lymphoma Trial in Worldwide (Duvelisib, Placebo, Rituximab)
Terminated
- Follicular Lymphoma
- Duvelisib
- +2 more
-
Frankston, Victoria, Australia
- +4 more
Mar 15, 2021
Follicular Lymphoma, DLBCL Trial in Worldwide (Obinutuzumab, Pinatuzumab Vedotin, Polatuzumab Vedotin)
Completed
- Follicular Lymphoma
- Diffuse Large B-Cell Lymphoma
- Obinutuzumab
- +3 more
-
Los Angeles, California
- +40 more
Feb 20, 2020
Follicular Lymphoma, Small Lymphocytic Lymphoma, Lymphoplasmacytic Lymphoma Trial in Worldwide (Idelalisib)
Completed
- Follicular Lymphoma
- +3 more
-
Fullerton, California
- +40 more
Jun 14, 2019
Follicular Lymphoma Trial in Italy (Rituximab, Mitoxantrone, Bendamustine)
Completed
- Follicular Lymphoma
- Rituximab, Mitoxantrone, Bendamustine
-
Meldola, Forlì-Cesena, Italy
- +36 more
Feb 29, 2016
Follicular Lymphoma Trial in Worldwide (fludarabine, rituximab, VELCADE)
Non Hodgkin Lymphoma, Follicular Lymphoma Trial in Italy (LR-CHOP21)
Unknown status
- Non Hodgkin Lymphoma
- Follicular Lymphoma
-
Alessandria, Italy
- +17 more
Oct 12, 2011
Follicular Lymphoma Trial in Italy (R-CVP, R-CHOP, R-FM)
Unknown status
- Follicular Lymphoma
- R-CVP
- +2 more
-
Acquaviva delle fonti (BA), Italy
- +81 more
Feb 14, 2011
Follicular Lymphoma Trial in Bologna (FM+R, Zevalin (Ibritumomab Tiuxetan))
Completed
- Follicular Lymphoma
- FM+R
- Zevalin (Ibritumomab Tiuxetan)
-
Bologna, BO, ItalyIstituto di Ematologia e Oncologia Medica SerĂ gnoli
Mar 10, 2009